Table 1.
Vitamin Intervention for Stroke Prevention (VISP) Trial Demographics at the Time of Randomization
| VISP cohort (n = 488) | |
| Treatment Arm, n (%) | |
| High Dose | 225 (47) |
| Low Dose | 251 (53) |
| Age, y | |
| Mean (SD) | 66 (±11) |
| Sex, n (%) | |
| Male | 310 (64) |
| Weakest LIMB, n (%) | |
| Arm | 333 (67) |
| Stroke onset to randomization | |
| Days | 72.5 (±31.2) |
| Body mass index (BMI) | |
| N-Miss | 7 |
| Mean (SD) | 28.54 (6.47) |
| Hypertension, n (%) | |
| N-Miss | 1 |
| No | 114 (23) |
| Yes | 383 (77) |
| Ever smoker, n (%) | |
| N-Miss | 1 |
| No | 173 (36) |
| Yes | 314 (64) |
| Diabetes mellitus type II, n (%) | |
| No | 331 (68) |
| Yes | 157 (32) |
| Ancestry, n (%) | |
| European | 347 (73) |
| African | 92 (19) |
| Other | 37 (8) |
Information is presented as counts (%) or means (SD).